HomeCompareZSAN vs MO

ZSAN vs MO: Dividend Comparison 2026

ZSAN yields 358.68% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZSAN wins by $5209.12M in total portfolio value
10 years
ZSAN
ZSAN
● Live price
358.68%
Share price
$0.56
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5209.20M
Annual income
$3,364,155,661.75
Full ZSAN calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — ZSAN vs MO

📍 ZSAN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZSANMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZSAN + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZSAN pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZSAN
Annual income on $10K today (after 15% tax)
$30,487.80/yr
After 10yr DRIP, annual income (after tax)
$2,859,532,312.49/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, ZSAN beats the other by $2,859,507,689.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZSAN + MO for your $10,000?

ZSAN: 50%MO: 50%
100% MO50/50100% ZSAN
Portfolio after 10yr
$2604.64M
Annual income
$1,682,092,315.14/yr
Blended yield
64.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

ZSAN
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZSAN buys
0
MO buys
11
PoliticianChamberTickerTypeAmountDate
Ro Khanna🏢 House$MO▲ Buy$1,000 - $15,0002025-08-04
Sheri Biggs🏢 House$MO▼ Sell$1,001 - $15,0002025-03-19
Pete Sessions🏢 House$MO▼ Sell$1,001 - $15,0002024-09-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-03-20
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-02-13
Virginia Foxx🏢 House$MO▼ Sell$1,001 - $15,0002024-01-16
Virginia Foxx🏢 House$MO▲ Buy$1,001 - $15,0002024-01-11
Ro Khanna🏢 House$MO▼ Sell$1,001 - $15,0002024-01-10
Ro Khanna🏢 House$MO▲ Buy$1,001 - $15,0002024-01-10
Virginia Foxx🏢 House$MO▼ Sell$15,001 - $50,0002024-01-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZSANMO
Forward yield358.68%6.27%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%22.6%
Portfolio after 10y$5209.20M$77.7K
Annual income after 10y$3,364,155,661.75$28,968.54
Total dividends collected$5034.10M$72.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: ZSAN vs MO ($10,000, DRIP)

YearZSAN PortfolioZSAN Income/yrMO PortfolioMO Income/yrGap
1← crossover$46,568$35,868.01$10,558$768.31+$36.0KZSAN
2$205,931$156,102.94$11,352$1,015.87+$194.6KZSAN
3$865,496$645,150.13$12,482$1,367.86+$853.0KZSAN
4$3,460,164$2,534,083.72$14,103$1,883.39+$3.45MZSAN
5$13,170,607$9,468,231.28$16,472$2,664.91+$13.15MZSAN
6$47,774,260$33,681,710.63$20,024$3,897.79+$47.75MZSAN
7$165,300,693$114,182,234.19$25,537$5,933.74+$165.28MZSAN
8$546,100,449$369,228,707.89$34,478$9,476.77+$546.07MZSAN
9$1,724,339,796$1,140,012,314.98$49,776$16,022.63+$1724.29MZSAN
10$5,209,199,243$3,364,155,661.75$77,699$28,968.54+$5209.12MZSAN

ZSAN vs MO: Complete Analysis 2026

ZSANStock

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Full ZSAN Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this ZSAN vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZSAN vs SCHDZSAN vs JEPIZSAN vs OZSAN vs KOZSAN vs MAINZSAN vs PMZSAN vs BTIZSAN vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.